SUPERNUS PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Supernus Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q3 2024.
  • Supernus Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 55.2M shares, a 1.08% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 55.2M +589K +1.08% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 55M +453K +0.83% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 55M +495K +0.91% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 54.7M +92.6K +0.17% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 54.6M +577K +1.07% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 54.6M +1.1M +2.06% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 54.5M +1.08M +2.03% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 54.6M +377K +0.7% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 54.1M +873K +1.64% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 53.5M +348K +0.65% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 53.4M +392K +0.74% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 54.3M +998K +1.87% Dec 31, 2021 10-K 2023-03-09
Q3 2021 53.2M +511K +0.97% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 53.1M +521K +0.99% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 53M +457K +0.87% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 53.3M +388K +0.73% Dec 31, 2020 10-K 2022-04-13
Q3 2020 52.7M +207K +0.4% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 52.6M +175K +0.33% Jun 30, 2020 10-Q 2020-08-17
Q1 2020 52.5M +163K +0.31% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 52.9M +552K +1.06% Dec 31, 2019 10-K 2021-03-08
Q3 2019 52.5M +206K +0.39% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 52.4M +270K +0.52% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 52.4M +740K +1.43% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 52.3M +1M +1.95% Dec 31, 2018 10-K 2020-02-28
Q3 2018 52.3M +995K +1.94% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 52.2M +1.45M +2.85% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 51.6M +1.41M +2.8% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 51.3M +1.34M +2.69% Dec 31, 2017 10-K 2019-03-01
Q3 2017 51.3M +1.72M +3.48% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 50.7M +1.23M +2.48% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 50.2M +805K +1.63% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 50M +967K +1.97% Dec 31, 2016 10-K 2018-03-01
Q3 2016 49.5M +853K +1.75% Sep 30, 2016 10-Q 2017-01-20
Q2 2016 49.5M +1.06M +2.2% Jun 30, 2016 10-Q/A 2017-01-23
Q1 2016 49.4M +1.91M +4.02% Mar 31, 2016 10-Q/A 2017-01-20
Q4 2015 49M +6.03M +14% Dec 31, 2015 10-K 2017-03-16
Q3 2015 48.7M +5.76M +13.4% Sep 30, 2015 10-Q/A 2017-01-20
Q2 2015 48.4M +6.31M +15% Jun 30, 2015 10-Q/A 2017-01-23
Q1 2015 47.5M +5.47M +13% Mar 31, 2015 10-Q/A 2017-01-20
Q4 2014 43M +2.99M +7.48% Dec 31, 2014 10-K/A 2017-01-20
Q3 2014 42.9M Sep 30, 2014 10-Q/A 2017-01-20
Q2 2014 42.1M Jun 30, 2014 10-Q 2014-08-12
Q1 2014 42M +11.2M +36.1% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 40M 0 0% Dec 31, 2013 10-K 2015-03-12
Q1 2013 30.9M +29.2M +1736% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 40M +38.3M +2305% Dec 31, 2012 10-K 2014-03-21
Q3 2012 24.5M Sep 30, 2012 10-Q 2012-11-02
Q2 2012 24.5M Jun 30, 2012 10-Q 2012-08-13
Q1 2012 1.68M Mar 31, 2012 10-Q 2012-06-08
Q4 2011 1.66M Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.